IP Library Granted Patent US 12,237,074
Granted Patent B2
US 12,237,074 · App. 17/137,093 · Granted Feb 25, 2025

System, method, and non-transitory computer-readable storage media related to correction of vision defects using a visual display

Inventors: Richard C. Freeman (Tulsa, OK); Michael H. Freeman (Tulsa, OK); Mitchael C. Freeman (Sapulpa, OK); Chad Boss (Tulsa, OK); Jordan Boss (Tulsa, OK)
Assignee: RAYTRX, LLC
G16H30/40A61B3/0025A61B3/024A61B3/032A61B3/12G16H10/60G16H30/20G16H50/20A61F9/08G16H70/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,237,074
App. No.
17/137,093
Granted
Feb 25, 2025
Kind
B2
Abstract

A method of at-home monitoring of eye conditions using a head mounted display that is capable of establishing a visual model associated with a patient. The visual model may include data related to a quality of the patient's vision. The patient may use the system to establish a visual model periodically, such as daily, and the system may compare the visual model to previous visual models and send an alert to the patient's physician if changes meeting a given criteria are detected. This may allow the physician to immediately take steps to save the patient's eyesight where a delay in treatment may result in vision loss.

Claims (18)

1. A method of at-home monitoring of eye conditions, the method comprising:

providing a system to a patient, the system comprising an augmented reality head mounted display, a database, and a model controller where the model controller is configured to:

establish a visual model comprising one or more boundaries indicating an area to be modified within the patient's field of vision and to store the visual model in the database, the visual model includes data related to a quality of the patient's vision, and the data includes data acquired using eye tracking;

receive an image from a camera associated with the patient;

generate an image distortion map including shifting image data located within the one or more boundaries outwardly along a plurality of rays starting at an estimated center point of the area to be modified within the patient's field of vision to outside the one or more boundaries such that the image data from the center point to an edge of the image is compressed from the one or more boundaries to the edge of the image;

modulate the image based on the image distortion map to produce an intentionally distorted image; and

project the intentionally distorted image onto the head mounted display within the patients usable field of vision;

testing the patient's eyes with the system to produce the visual model;

allowing the patient to manipulate the one or more boundaries of the visual model to produce a modified visual model;

comparing the modified visual model with prior visual models to detect changes; and

notifying a physician of the changes.

2. The method of claim 1 where testing the patient's eyes occurs regularly.

3. The method of claim 1 where the database is cloud-based.

4. The method of claim 1 where notifying the physician of the changes occurs when the changes meet designated criteria.

5. The method of claim 1 where notifying the physician of the changes occurs via radio frequency transmission.

6. The method of claim 1 where testing the patent's eyes is performed by the patient.

7. The method of claim 1 where testing the patient's eyes is performed at the patient's home.

8. The method of claim 1 where the physician is notified remotely if certain criteria indicating deterioration in the eye occurs.

Assignments (3)
SECURITY INTEREST Recorded Apr 5, 2024
From: RAYTRX LLC
To: SAGE CONSULTING & WAGE PRESERVATION, INC.
Reel/Frame 067526/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2021
From: FREEMAN, MICHAEL H.; FREEMAN, MITCHAEL C.; BOSS, JORDAN
To: RAYTRX, LLC
Reel/Frame 054940/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2021
From: FREEMAN (DECEASED), RICHARD C.; BOSS (DECEASED), CHAD
To: RAYTRX, LLC
Reel/Frame 054915/0762 →
Continuity (5)
Continuation In Part 16173719 · Oct 29, 2018
Continuation 15940561 · Mar 29, 2018
Continuation 15073144 · Mar 17, 2016
Provisional Application 62134422 · Mar 17, 2015
Related Publication 20220005587A1 · Jan 6, 2022
References Cited (56)
US 7600873B2 · Grundig · 2009 [cited by applicant]
US 9651786B1 · Browne · 2017 [cited by applicant]
US 10323904B1 · Batten · 2019 [cited by applicant]
US 20020063807A1 · Margulis · 2002 [cited by applicant]
US 20030223038A1 · Alster et al. · 2003 [cited by applicant]
US 20040057013A1 · Cappo · 2004 [cited by examiner]
US 20050036109A1 · Blum et al. · 2005 [cited by applicant]
US 20050280603A1 · Aughey et al. · 2005 [cited by applicant]
US 20070121070A1 · Alster · 2007 [cited by examiner]
US 20090218400A1 · Boss et al. · 2009 [cited by applicant]
US 20100011959A1 · Marra · 2010 [cited by applicant]
US 20100149073A1 · Chaum et al. · 2010 [cited by applicant]
US 20120281181A1 · Chen et al. · 2012 [cited by applicant]
US 20130172902A1 · Lightcap et al. · 2013 [cited by applicant]
US 20130215147A1 · Hilkes et al. · 2013 [cited by applicant]
US 20130329190A1 · Lewis et al. · 2013 [cited by applicant]
US 20130335543A1 · Hilkes et al. · 2013 [cited by applicant]
US 20140094655A1 · Newman · 2014 [cited by applicant]
US 20140098226A1 · Pletcher et al. · 2014 [cited by applicant]
US 20140160264A1 · Taylor et al. · 2014 [cited by applicant]
US 20140184475A1 · Tantos · 2014 [cited by examiner]
US 20140275760A1 · Lee et al. · 2014 [cited by applicant]
US 20140283429A1 · Sullivan et al. · 2014 [cited by applicant]
US 20150193984A1 · Bar-Zeev et al. · 2015 [cited by applicant]
US 20150355481A1 · Hilkes et al. · 2015 [cited by applicant]
US 20160037849A1 · Shearman et al. · 2016 [cited by applicant]
US 20160091968A1 · Angelo et al. · 2016 [cited by applicant]
US 20160247418A1 · Folzenlogen et al. · 2016 [cited by applicant]
US 20160252325A1 · Sammut et al. · 2016 [cited by applicant]
US 20160262608A1 · Krueger · 2016 [cited by applicant]
US 20160270648A1 · Freeman et al. · 2016 [cited by applicant]
US 20160270656A1 · Samec et al. · 2016 [cited by applicant]
US 20160321404A1 · Ginsburg · 2016 [cited by examiner]
US 20170007351A1 · Yu · 2017 [cited by applicant]
US 20170011706A1 · Namkung et al. · 2017 [cited by applicant]
US 20170068119A1 · Antaki et al. · 2017 [cited by applicant]
US 20170094167A1 · Riedel · 2017 [cited by applicant]
US 20170135577A1 · Komogortsev · 2017 [cited by examiner]
US 20170143202A1 · Palanker et al. · 2017 [cited by applicant]
US 20170293380A1 · Chauveau et al. · 2017 [cited by applicant]
US 20170323615A1 · Hazra et al. · 2017 [cited by applicant]
US 20180116742A1 · Dell et al. · 2018 [cited by applicant]
US 20180250085A1 · Simi et al. · 2018 [cited by applicant]
US 20190201693A1 · Nirenberg · 2019 [cited by applicant]
US 20190353457A1 · Northrup · 2019 [cited by applicant]
US 20210149173A1 · Knoblich et al. · 2021 [cited by applicant]
CN 105188516A · 2015 [cited by applicant]
EP 4052647 · 2022 [cited by applicant]
JP H09245195 · 1997 [cited by applicant]
WO 2014140849A2 · 2014 [cited by applicant]
WO 2016149536 · 2016 [cited by applicant]
International Search Report and Written Opinion (PCT/US21/054223); Date of Mailing: Jan. 11, 2022. [cited by applicant]
Extended European Search Report in European Patent Application No. 19833423.7; dated Aug. 20, 2022. [cited by applicant]
Office Action received in Chinese Patent Application No. 2018800416969; dated Jan. 12, 2023. [cited by applicant]
European Report in European Patent Application No. 18790963.5; dated Jun. 5, 2023. [cited by applicant]
Office Action dated Aug. 22, 2022 in Mexico Patent Application No. MX/a/2019/012610; Mexican Institute of Industrial Property. [cited by applicant]